Tri-Heal (TB-500 + BPC-157 + KPV) Dosage Protocol
Three-peptide repair blend — TB-500 25mg + BPC-157 10mg + KPV 10mg in one vial; the combination is not clinically validated.
Fixed ratio: TB-500 25 mg : BPC-157 10 mg : KPV 10 mg — a 5:2:2 blend. Every withdrawal keeps that ratio, so the components cannot be dosed independently.
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers. Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →Mix & measure Tri-Heal (TB-500 + BPC-157 + KPV) · 45 mg
Dosing & Reconstitution Guide
One practical dilution for the combined 45 mg blend, with once-daily dosing step by step
Standard / Gradual Approach (3 mL = ~15 mg/mL blend)
Reconstitute: Add 3.0 mL bacteriostatic water to the single 45 mg blend vial → ~15 mg/mL total (TB-500 25 mg → ~8.33 mg/mL, BPC-157 10 mg → ~3.33 mg/mL, KPV 10 mg → ~3.33 mg/mL).
Standard daily dose: 10 units (0.10 mL) once daily — 0.833 mg TB-500 + 0.333 mg BPC-157 + 0.333 mg KPV per dose.
Easy measuring: At this dilution, 10 units = 0.10 mL on a U-100 syringe. The 3.0 mL dilution keeps the daily draw on a clean, easy-to-read mark.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Advanced / Aggressive Approach (3 mL = double dose, 20 u)
Advanced daily dose: 20 units (0.20 mL) once daily — 1.667 mg TB-500 + 0.667 mg BPC-157 + 0.667 mg KPV per dose.
Same dilution: Uses the identical 3.0 mL reconstitution as the Standard approach (~15 mg/mL total).
May split AM/PM: If 20 units exceeds comfort in one shot, divide into two 10-unit injections (morning and evening).
Site rotation: Monitor for injection-site irritation and rotate sites daily.
Note: Values under 10 units are hard to measure accurately for micro-dosing. If higher precision is required, consider 50- or 30-unit syringes. The advanced schedule is intended for shorter, more intensive research windows.
Why Tri-Heal (TB-500 + BPC-157 + KPV) draws research interest
These are the directions researchers and the peptide community most often explore Tri-Heal (TB-500 + BPC-157 + KPV) for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Tissue repair
Explored in preclinical research on wound healing and soft-tissue repair, drawing on animal-only studies of TB-500 and BPC-157.
Injury & recovery
Investigated in animal models for tendon, ligament and muscle recovery; the three-peptide blend itself is not clinically validated.
Anti-inflammatory research
KPV and BPC-157 are studied for anti-inflammatory activity in preclinical, animal-only research, with no approved human indication.
Gut & mucosal repair
BPC-157 is investigated in rodent studies of gut and mucosal lining repair; its effects in humans remain uncharacterized.
Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
Frequency: one subcutaneous (or IM) injection each day. At 10 units daily, each component accumulates to roughly 2.3 mg per week (about 2,331 mcg of BPC-157 and of KPV weekly, and ~5.8 mg TB-500). Reconstitute with 3.0 mL bacteriostatic water for an easy 10-unit measurement. These figures are illustrative for a research blend, not approved human dosing.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.
Reconstitution Steps
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Release it slowly down the vial’s inner wall to limit foaming and avoid splashing the powder directly.
Gently swirl until the blend is fully dissolved — do not shake.
Label the vial with the reconstitution date and store at 2–8 °C.
Supplies Needed
Quantities below assume a once-daily 4–8 week course using the combined 45 mg blend vial.
One 45 mg vial reconstituted with 3.0 mL covers about 30 standard (10-unit) doses.
- 4 weeks (standard): ~1 vial
- 8 weeks (standard): ~2 vials
- 8 weeks (advanced): ~3 vials
- Per injection: 1 syringe
- 4 weeks (once daily): ~30 syringes
- 8 weeks (once daily): ~60 syringes
Use ~3.0 mL per 45 mg vial for reconstitution.
- 4 weeks (1 vial): ~3 mL → 1 bottle
- 8 weeks (2–3 vials): ~6–9 mL → 1 bottle
One for the vial stopper + one for the injection site each day.
- Per injection: 2 swabs
- 8 weeks (once daily): ~120 swabs → 1–2 boxes
Dosing Protocol
A suggested daily approach for the combined blend.
- ▪Cycle Length: Typically 4–8 weeks, then reassess before any further use.
- ▪Reminder: The three-peptide combination has no human trials; treat all targets as research hypotheses.
Storage Instructions
Correct storage is what preserves the peptides’ stability and activity.
- ▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
- ▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
- ▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
- ▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.
Important Notes
Practical points that keep daily administration safe and consistent.
- ▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
- ▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
- ▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
- ▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
- ▪Regulatory note: All three peptides are unapproved research chemicals and not FDA-approved for human use. BPC-157 and TB-500 are WADA-prohibited; KPV should be treated as banned in sport[10].
How This Works
Tri-Heal combines three peptides in one vial, each with a distinct proposed mechanism drawn from preclinical work:
TB-500 is a synthetic fragment reproducing the active region (Ac-LKKTETQ) of Thymosin Beta-4[1][5]. Its core proposed action is sequestering G-actin to help regulate actin polymerization, the process behind the cell migration central to wound healing; preclinical work also links it to angiogenesis and reduced fibrosis.
BPC-157 is a synthetic pentadecapeptide derived from a sequence in human gastric juice, studied in animals for tendon, ligament, muscle and gut repair and for angiogenic, cytoprotective effects. Human efficacy is unproven.
KPV is the tripeptide Lys-Pro-Val, the C-terminal fragment of α-MSH, investigated in cell and animal models as an anti-inflammatory agent acting on inflammatory signalling.
Important caveat: each peptide’s data is preclinical / animal-only, and the three-way combination has zero clinical validation — there are no human trials of this stack. The figures and targets here are research hypotheses, not established outcomes.
All three are unapproved research chemicals, none FDA-approved, presented here for research and educational purposes only.
Lifestyle Factors
Habits that may support recovery alongside the protocol.
- ▪Nutrition: Keep protein intake adequate to give tissue repair the building blocks it needs.
- ▪Activity & rest: Pair appropriate movement with real recovery time and avoid overtraining during an injury-recovery phase.
- ▪Sleep: Aim for 7–9 hours to support the body’s natural repair processes.
- ▪Stress: Manage stress with evidence-based practices, since it influences overall healing.
Potential Benefits & Side Effects
What preclinical and veterinary literature describe for the individual peptides; human evidence is limited and the combination is unstudied, so individual results vary.
Potential Benefits
- ▪Tissue repair (preclinical): TB-500 and BPC-157 are reported in animal models to support wound healing, angiogenesis and tendon/ligament repair[5][6].
- ▪Anti-inflammatory (preclinical): KPV has shown anti-inflammatory activity in cell and animal models[11].
- ▪Tolerability (veterinary): The components are generally well tolerated in animal studies, with occasional mild injection-site reactions.
- ▪Note on humans: These benefits are not established in humans, and the three-peptide combination has no clinical trials[13].
Common Side Effects
- ▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
- ▪Unknown long-term profile: Human safety data is limited and the blend is unstudied, so caution and monitoring are advised.
- ▪Sport restriction: TB-500 and BPC-157 are WADA-prohibited; treat KPV as banned for athletes.
Injection Technique
General subcutaneous technique, following established clinical best-practice guidance[14][15].
Pre-Injection Preparation
- ▪Wash your hands well with soap and water.
- ▪Wipe the vial stopper with an alcohol swab and let it air-dry.
- ▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
- ▪Draw the intended dose, then check for air bubbles and push any out.
Injection Procedure
- ▪Pinch a skinfold at the chosen site between thumb and forefinger.
- ▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
- ▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
- ▪Press the plunger slowly and steadily until it’s fully down.
- ▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
Post-Injection Care
- ▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
- ▪Return the reconstituted vial to the fridge right away.
- ▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
- ▪Watch the site for excess redness, swelling, or signs of infection.
Recommended Source
For high-purity research peptides, we point researchers to Prime Lab Peptides.
Why Prime Lab Peptides?
- ▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.
- ▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
- ▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
- ▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
- ▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
References
- 1
FASEB JournalBiological activities of thymosin beta-4 mapped to active peptide sequences, including the fragment marketed as TB-500.
- 2
Journal of Chromatography A (PubMed)Doping-control analysis of TB-500 as a synthetic thymosin beta-4 fragment in biological samples.
- 3
WADA Scientific ResearchInvestigation of TB-500 metabolism, synthesis of its metabolites, and detection limits.
- 4
Racing Medication & Testing ConsortiumThymosin beta-4 regulatory bulletin covering TB-500 use in equine sports medicine.
- 5
Journal of Investigative Dermatology (PubMed)Thymosin beta-4 accelerates wound healing in a preclinical model.
- 6
FASEB Journal (PubMed)Active-site mapping of thymosin beta-4 fragments for angiogenesis and cell migration.
- 7
Peptide Storage GuideBest practices for storing lyophilized peptides (temperature, humidity and light protection).
- 8
Bacteriostatic Water GuidanceBacteriostatic water for injection: multi-dose vial stability and handling.
- 9
NCBI BookshelfBest practices for subcutaneous injection: aseptic technique and site rotation.
- 10
WADA Prohibited ListClassification of TB-500 as a prohibited substance in competitive sport.
- 11
Journal of Investigative DermatologyThymosin beta-4 wound-healing mechanisms: collagen deposition, angiogenesis and granulation tissue.
- 12
Journal of Chromatography B (PubMed)Quantification of TB-500 metabolites and screening of wound-healing activity (prodrug hypothesis).
- 13
ClinicalTrials.govTrial registry for full-length thymosin beta-4 (e.g., dermal and ocular indications); no completed efficacy trials of the TB-500 fragment.
- 14
Centers for Disease Control and Prevention (CDC)Subcutaneous injection technique: angle, site and no-aspiration guidance.
- 15
Subcutaneous Injection Technique (Patient Education)How to administer a subcutaneous injection: clinical technique guidelines.
- 16
Prime Lab PeptidesTB-500 (5 mg) product page — purity specifications and certificates of analysis.
Tri-Heal (TB-500 + BPC-157 + KPV) — frequently asked questions
How do I reconstitute a 45 mg vial of Tri-Heal (TB-500 + BPC-157 + KPV)?
Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.
How much bacteriostatic water should I add to Tri-Heal (TB-500 + BPC-157 + KPV)?
There is no single correct amount — more water simply spreads the same 45 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.
What do the "units" on an insulin syringe mean?
On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.
How should I store Tri-Heal (TB-500 + BPC-157 + KPV) after mixing?
Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.
How many doses does a 45 mg vial of Tri-Heal (TB-500 + BPC-157 + KPV) provide?
Divide the vial strength of 45 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.
Is Tri-Heal (TB-500 + BPC-157 + KPV) approved for human use?
No. Tri-Heal (TB-500 + BPC-157 + KPV) is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.
New protocols & dosing updates
Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.